These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20153080)
1. Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients. Parks T; Wallis S; Wilson J; Gkrania-Klotsas E; Nicholl C J Hosp Infect; 2010 Apr; 74(4):403-5. PubMed ID: 20153080 [No Abstract] [Full Text] [Related]
2. Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia. Alzahrani N; Johani SA Ann Saudi Med; 2013; 33(2):198-9. PubMed ID: 23563012 [No Abstract] [Full Text] [Related]
4. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459 [TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Bouza E; Muñoz P; Alonso R Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea. Bishara J; Wattad M; Paul M Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329 [No Abstract] [Full Text] [Related]
8. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. Wilcox MH; Howe R J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942 [TBL] [Abstract][Full Text] [Related]
9. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea. Tart SB J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin therapy for severe Clostridium difficile-associated diarrhea. Huggan PJ; Murdoch DR Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330 [No Abstract] [Full Text] [Related]
12. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection. Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480 [TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent Clostridium difficile infection: a systematic review. O'Horo JC; Jindai K; Kunzer B; Safdar N Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210 [TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727 [TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile-associated disease treatment response depends on definition of cure. Lawrence SJ; Dubberke ER; Johnson S; Gerding DN Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331 [No Abstract] [Full Text] [Related]
16. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity. Di X; Bai N; Zhang X; Liu B; Ni W; Wang J; Wang K; Liang B; Liu Y; Wang R Braz J Infect Dis; 2015; 19(4):339-49. PubMed ID: 26001980 [TBL] [Abstract][Full Text] [Related]
17. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset. Kimura T; Snijder R; Sugitani T J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950 [TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study. Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244 [TBL] [Abstract][Full Text] [Related]